AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Metastasis to the breast of other cancers are rare but should be recognized.
2003 OCT 2 - (NewsRx.com & NewsRx.net) -- Metastasis of other tumors to the breast is rare, but cytologists should be aware of distinguishing features.
According to a study from England, "The occurrence of metastatic tumors in the breast is uncommon and it is crucial for cytologists to be aware and distinguish them cytologically from primary breast tumors in fine needle aspirates. In the present retrospective study of 11 cases, over a 20 yr period, we discuss the cytological features of extramammary metastatic tumors in the breast. A brief attempt has been made to discuss the past literature.
"The 11 metastatic tumors included 4 hematolymphoid neoplasms, 2 melanomas, 2 metastatic sarcomas, and 3 metastatic carcinomas. A prior clinical diagnosis of the primary tumor was obtained in 7 cases. Immunohistochemistry or histology following a cytological diagnosis confirmed all the cases," wrote R.K. Hejmadi and colleagues.
The researchers concluded: "The main objective of ...
- Breast cancer stem cells create metastatic tumors. (News from the Lab).(Brief...
- Newspaper article from: BioWorld Week March 10, 2003 700+ words
Breast cancer accounts for more than 40,000 deaths...Prospective identification of tumorigenic breast cancer cells." Its senior author is cancer...were isolated from primary or metastatic breast cancers removed from nine women treated...
- Dendreon Phase 1 Study Results Demonstrate Promising Clinical Activity of...
- Press release article from: Business Wire June 7, 2004 700+ words
...observed in patients with HER2/neu positive breast, ovarian and colorectal cancers treated...applicability to other solid tumors in addition to breast cancer," said Prema Peethambaram, M...positive ovarian (4), colorectal (3) and breast (3) cancer. Patients had received a...
- Progen's PI-88 Effectiveness Against Metastatic Tumors in Rats and Mice...
- Press release article from: Business Wire October 8, 1998 700+ words
...effective therapy for invasive and metastatic tumors. Anderson presented to the Metastasis...two animal models of metastatic breast cancer. In the first model using...88 may be effective against metastatic tumors expressing varying levels of heparanase...
- Introgen Collaborators at M.D. Anderson Cancer Center Identify New Class Of...
- Press release article from: PR Newswire October 17, 2002 700+ words
...controlled, randomized phase 3 clinical trials with ADVEXIN for the treatment of head and neck cancer, a phase 2 study in breast cancer, as well as phase 1 trials in prostate, ovarian, bladder, and brain cancers, and has completed phase 2 studies in...
- Multi-Center Study Shows RITA Medical Systems Radiofrequency (RF) Technology...
- Press release article from: PR Newswire June 2, 2003 700+ words
...that its minimally invasive technology may in the future be applied to other types of tumors, including tumors of the lung, breast, uterus, prostate and kidney. The Company has received regulatory clearance in major markets worldwide, including the United...
- Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately...
- Press release article from: PR Newswire July 9, 2008 700+ words
...Current Technologies Accurately Differentiating Primary From Metastatic Tumors is Critical for Optimal Treatment REHOVOT, Israel and...of microRNAs in accurately differentiating primary from metastatic tumors of the brain, have been published online in the peer...
- Carrier cells mediate the transfer of oncolytic parvovirus to metastatic tumors.
- Newspaper article from: Biotech Week June 2, 2004 700+ words
...JUN 2 - (NewsRx.com & NewsRx.net) -- Carrier cells mediate the transfer of oncolytic parvovirus to metastatic tumors. According to a study from Germany, "over the last few years, naturally occurring or genetically manipulated...
- REXIN-G Shrinks Metastatic Tumors and Triples Survival Time in...
- Press release article from: PR Newswire January 20, 2009 700+ words
SAN MARINO, Calif., Jan. 20 /PRNewswire/ -- Epeius Biotechnologies (httpwww.epeiusbiotech.com/) announced the results of a U.S. Phase I/II study evaluating the safety and efficacy of Rexin-G in chemotherapy-resistant metastatic pancreatic cancer (ASCO GI Symposium, #249; Sant P Chawla, P.I., Santa
- New class of drugs reduces metastatic tumors by 80% in animal models.
- Newspaper article from: Angiogenesis Weekly November 29, 2002 700+ words
2002 NOV 29 - (NewsRx.com & NewsRx.net) -- A preclinical study published in the journal Clinical Cancer Research demonstrates the potent activity of a new class of anticancer agents. Introgen Therapeutics, Inc. (NASDAQ:INGN) and its collaborators at the University of Texas M.D. Anderson Cancer
- New class of drugs reduces metastatic tumors by 80% in animal models.(Brief...
- Newspaper article from: Cancer Weekly November 26, 2002 700+ words
2002 NOV 26 - (NewsRx.com & NewsRx.net) -- A preclinical study published in the journal Clinical Cancer Research demonstrates the potent activity of a new class of anticancer agents. Introgen Therapeutics, Inc. (NASDAQ:INGN) and its collaborators at the University of Texas M.D. Anderson Cancer
Source: HighBeam Research, Metastasis to the breast of other cancers are rare but should be...